TSPO and myeloid sarcoma: Studies in MS, in contrast, have found astrocytes to be major contributors of TSPO, particularly in chronic and chronic active lesions [13], and it is hypothesized that astrocytic TSPO may serve a neuroprotective role by providing increased neurotrophic support [9, 26].